A vaccine against the disease associated with a virus carried by migrating wildebeest
The chance vaccineFor more than ten years, the study of this singular virus fascinates Benjamin Dewals who is now a Researcher Associate at the FNRS in the Immunology and Vaccinology Unit of the Faculty of Veterinary Medicine of the University of Liege. When he began his doctoral thesis on this subject in 2002, his objective was to uncover all the secrets of this pathology. He did such a good job that he succeeded in discovering a vaccine! “The laws of chance”, he says modestly with a smile. An epidemiological dead endHowever, the AlHV-1 virus possesses a specificity: its latency. At the commencement of their study, Benjamin Dewals and the team from Liege noticed an astonishing characteristic thanks to experiments carried out on rabbits. “Once the animal is infected, it dies, but is incapable of transmitting the virus to another animal. It is an epidemiological dead end. This drew our attention because we observed a lymphoproliferation, a proliferation of lymphocytes. The viral load in terms of DNA increases exponentially. We then asked ourselves whether the growing infection we saw was not due to a latent infection”, he explains. This assessment went against the majority of theories that had been put forward up to that point. Most scientists generally affirmed that very few cells were infected. Some of them even went as far as to theorize that only one cell in 10,000 or 100,000 was infected. Benjamin Dewals was able to demonstrate that the opposite was true. ![]() (1) Palmeira L., Sorel O., B.G.Dewals et al., An essential role for γ-herpesvirus latency-associated nuclear antigen homolog in an acute lymphoproliferative disease of cattle, PNAS, May 2013, Vol. 110, n°21 |
|
|||||||||||||||||||||
© 2007 ULi�ge
|
||